The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer.
 
Angela Green
Consulting or Advisory Role - Merck
Research Funding - AADi (Inst); Lilly (Inst); Mereo BioPharma (Inst)
 
Qin Zhou
No Relationships to Disclose
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - Intelligencia; Mirati Therapeutics
 
William Zammarrelli
No Relationships to Disclose
 
Britta Weigelt
Employment - AstraZeneca (I)
Stock and Other Ownership Interests - Repare Therapeutics (I)
Consulting or Advisory Role - Bain Capital Life Sciences (I); Goldman Sachs (I); PAIGE (I); Repare Therapeutics (I); SAGA Diagnostics (I); Volition RX (I)
Research Funding - Repare Therapeutics
 
Lora H Ellenson
No Relationships to Disclose
 
Rashmi Chhetri-Long
No Relationships to Disclose
 
Pooja Shah
No Relationships to Disclose
 
Vania Hom
Travel, Accommodations, Expenses - DualityBio
 
Joseph P. Erinjeri
Consulting or Advisory Role - AstraZeneca
 
Iva Petkovska
No Relationships to Disclose
 
Sarat Chandarlapaty
Stock and Other Ownership Interests - Odyssey Biosciences; Totus Medicines
Consulting or Advisory Role - AstraZeneca/MedImmune; Boxer Capital; Inivata; Lilly; Novartis; Paige.ai; Prelude Therapeutics; SAGA Diagnostics; Sanofi
Research Funding - Ambryx (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Novartis (Inst); Paige.ai (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for (1) targeting mutant ER with ER PROTACS and (2) targeting CDK4/6 with CDK4/6 PROTACS (Inst)
Travel, Accommodations, Expenses - Novartis Institutes for BioMedical Research
Other Relationship - Peerview; Targeted Oncology; WebMD
(OPTIONAL) Uncompensated Relationships - Odyssey Biosciences; Totus Medicines
 
Seth M. Cohen
No Relationships to Disclose
 
Rachel N. Grisham
Employment - Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Consulting or Advisory Role - AstraZeneca; Corcept Therapeutics; GlaxoSmithKline; Intellisphere; Myriad Genetics; Signatera; SpringWorks Therapeutics; Verastem
Research Funding - Bayer (Inst); Context Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); SpringWorks Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Aptitude Health; Cardinal Health; MCM Education; OncLive; Prime Oncology
(OPTIONAL) Uncompensated Relationships - Verastem
 
Jason A. Konner
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Research Funding - Immunogen
 
Maria M Rubinstein
Honoraria - MJH Life Sciences
Research Funding - ASCO (Inst); AstraZeneca (Inst); Debiopharm Group (Inst); Duality Biologics (Inst); Faeth Therapeutics (Inst); Merck (Inst)
 
William P. Tew
No Relationships to Disclose
 
Tiffany A. Troso-Sandoval
Honoraria - Biotheranostics/Hologic; Immunogen
Travel, Accommodations, Expenses - Bio Ascend
 
Carol Aghajanian
Leadership - GOG Foundation
Consulting or Advisory Role - AstraZeneca; Merck
Research Funding - Abbvie (Inst); Artios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Vicky Makker
Consulting or Advisory Role - ArQule; Clovis Oncology; DualityBio; Eisai; Faeth Therapeutics; GlaxoSmithKline; IBM; ITeos Therapeutics; Kartos Therapeutics; Karyopharm Therapeutics; Lilly; Merck; Novartis; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Eisai (Inst); Faeth Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; ESMO Congress; Merck
Other Relationship - IBM